Single Cell Analysis Market
                     Single Cell Analysis Market
Global Forecast to 2026
Single Cell Analysis Market is 
expected to reach 
$ 6.3 Billion by 2026
Growing at a 
CAGR of  15.1% (2021 – 2026)
The global single-cell analysis market is projected to reach USD 
6.3 billion by 2026 from USD 3.1 billion in 2021, at a CAGR of 
15.1% during the forecast period.
The consumables segment accounted for the largest share of the product 
segment in the single-cell analysis market in 2020.
Consumables accounted for the largest share of the single-cell analysis market in 2020. 
The large share of this segment can primarily be attributed to the frequent purchase of 
these products compared to instruments, which are considered a one-time investment. 
The wide applications of consumables in research and genetic exploration, exosome 
analysis, and isolation of RNA and DNA are also expected to drive market growth.
The research applications segment accounted for the largest share of 
the application segment in the single-cell analysis market in 2020
Based on applications, the single-cell analysis market is segmented into 
research and medical applications. The research applications segment 
accounted for the largest share of the single-cell analysis market in 2020. 
Increasing government initiatives in stem cell research and the wide usage 
of single-cell analysis in cancer research are the major factors driving the 
growth of the research applications segment.
    Key Market Player
    Danaher Corporation (US), 
    Merck KGAA (Germany), 
    QIAGEN N.V. (Netherlands), 
    Thermo Fisher Scientific, Inc. (US), 
    Promega Corporation (US), 
    Illumina, Inc. (US), 
    Fluidigm Corporation (US), 
   10X Genomics (US), and 
   Corning Incorporated (US).